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Abstract
Background: Random safety audits (RSA) are a safety tool enabling prevention of adverse events, but they have
not been widely used in hospitals. The aim of this study was to use RSAs to assess and compare the frequency of
appropriate use of infusion pump safety systems in a Neonatal Intensive Care Unit (NICU) before and after quality
improvement interventions and to analyse the intravenous medication programming data.
Methods: Prospective, observational study comparing the frequency of appropriate use of Alaris® CC smart pumps
through RSAs over two periods, from 1 January to 31 December 2012 and from 1 November 2014 to 31 January
2015. Appropriate use was defined as all evaluated variables being correctly programmed into the same device.
Between the two periods they were established interventions to improve the use of pumps. The information
recorded at the pumps with the new security system, also extracted for one year.
Results: Fifty-two measurements were collected during the first period and 160 measurements during the second
period. The frequency of appropriate use was 73.13 % (117/160) in the second period versus 0 % (0/52) in the first
period (p < 0.0001). Information was recorded on 44,924 infusions; in 46.03 % (20,680/44,924) of cases the drug
name was recorded. In 2.5 % (532/20,680) of cases there was an attempt to exceed the absolute limit.
Conclusions: Random Safety Audits were a very useful tool for detecting inappropriate use of pumps in the NICU.
The improvement strategies were effective for improving appropriate use and programming of the intravenous
medication infusion pumps in our NICU.
Keywords: Smart pumps, Random safety audits, Technology, Patient safety, Adverse events, Neonatal Intensive Care
Unit, Newborn
Background
Advances in neonatology care have achieved an increase
in the survival rate of premature and ill newborns. These
patients frequently require intravenous treatment which
poses a higher risk of adverse events [1]. The incidence
of medication-related errors in children is two- to three-
times higher than in adults. In addition, newborns are
the most vulnerable patients as their internal reserves,
which buffer the consequences of medication errors, are
more limited [2-4].
Furthermore, Neonatal Intensive Care Units (NICUs)
are highly complex units, not only because of the type of
patients they care for, but also because of the wide range
of technology they use. Multiple unplanned, critical situ-
ations occur in NICUs, which can lead to related events
through the inappropriate use of technological devices.
Healthcare technology is widely integrated into today’s
intensive care units. However, the prevalence of device-
related errors and their consequences for patients are
still not well-defined [5, 6].
For decades, industries dealing with high-risk situa-
tions, such as aviation, have developed safety tools (e.g.
checklists, root-cause analysis, failure mode and effects
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analysis, random safety audits) to decrease the possibility
of human error and to detect system failures [6, 7].
Given that safety is an essential component of the qual-
ity of care for hospitalised patients, all possible measures
should be used to try to reduce adverse events. However,
Random Safety Audits (RSA), a much-used tool in
industry due to their great ability to identify errors and
situations of potential risk, are still little-used in the hos-
pital environment. There is very little published data on
their use as a tool for safety and quality control [8, 9].
An RSA consists of continuously monitoring procedures
considered to be high risk in order to identify and ad-
dress error-prone points in the system that are difficult
to detect with other methods, and this before they cause
patient harm. The application of this method in a hos-
pital setting could be extremely valuable, as it evaluates
clinical practice in real time and provides immediate
feedback to the staff in the Unit [6, 7]. Moreover, this
method put in place by frontline clinical staff, only
requires simple training and involves a low cost of
implementation.
In addition, technologies to administer intravenous
medication which incorporate ever more advanced safety
systems and new safety software are being developed
and have demonstrated a positive impact on patient
quality of care, decreasing medication-related adverse
events. This also has a positive effect on healthcare
personnel by improving work flow, reducing legal risk,
and reducing costs [10].
The main purpose of RSAs is to continuously monitor
certain procedures. However another possible use would
be to consistently detect weaknesses and subsequently
apply interventions. The RSAs could measure the impact
of the interventions. In light of the scarce availability of
information about medication infusion pumps in NICUs
and the use of RSAs in hospitals, we established rounds
of audits on the use of pump safety systems. Given the
results, we designed quality improvement strategies.
New rounds of audits were later established to test the
efficacy of the interventions.
Thus, the objective of our study was to assess and
compare the frequency of appropriate use of the infusion
pump safety systems by using RSAs in a level III-C neo-
natal intensive care unit before and after an intervention
to improve infusion pump use, as well as to analyse the
intravenous programming data in our unit.
Methods
Prospective, observational study comparing two periods
through rounds of audits in which data related to the
use of Alaris® CC syringe infusion pump safety systems
was collected in a level III-C NICU with around 500 ad-
missions per year in intensive care. Our NICU is divided
into three areas for critical care – a large one with 10
beds and two small ones, one with 4 beds and the other
with 5 beds – and two additional areas with 24 medium-
care cots. The large area, NICU-A, is for full-term neo-
nates, surgical problems and patients transferred from
other hospitals. The other two areas, NICU-B and C,
house babies up to 30 weeks of age. The patient/nurse
ratio in the NICU is 2.1.
Physicians and nurses were surveyed according to the
modified Delphi technique on the technological devices
and procedures for which the recommendations for use
were apparently often not met, ensuring that the most
relevant equipment and procedures were included. This
was a structured methodology in which, through a ques-
tionnaire and group meetings (doctors and nurses), a
consensus was reached as to the resources and proce-
dures apparently affected by protocol non-compliance. A
total of 23 technological devices and procedures were se-
lected and 23 cards were produced, each containing the
variables to be evaluated for each device or procedure.
One of the resources audited was the medication
pumps.
In the first period (1 January 2012 to 31 December
2012) RSAs were performed on these 23 different re-
sources and procedures, one of which was the medica-
tion pumps. The data from this first period was analysed
in 2013, when it was discovered that the use of the
pumps was inappropriate in most cases. The program
was immediately installed and theoretical and practical
training was provided in workshops for doctors and
nurses. After a period of adaptation to the program,
all the information stored in the pumps in 2014
(shown in Fig. 2) was downloaded. In the second
period (1 November 2014 to 31 January 2015), there
were more RSAs, in this case only affecting the medica-
tion pumps, so a large number of data were collected in
only three months. The data presented correspond to the
first and second period, plus the downloaded information
stored in the pumps throughout 2014.
The first period for rounds of audits was from 1 January
2012 to 31 December 2012 (a calendar year); the objective
during this round was to understand the baseline position
in the Unit in relation to use of infusion pumps and other
devices/procedures. During the study period, two days
each week (normal working days or weekends/holidays)
and the shift (early or late) were selected at random. Early
shift was from 08:00 a.m. to 3:00 p.m. and late shift was
from 3:00 p.m. to 10:00 p.m. The night shift was not
audited as the investigators were not available. At the be-
ginning of each week, a person unrelated to the system
randomly drew two cards with the days of the week and
shifts (early or late) and the RSAs to be audited. On each
of these days, an investigator (EBS or MCPG) identified
devices or procedures that were to be audited and that
were in use on at least one patient, and audited all study
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variables for the selected procedures or equipment. The
NICU staff did not know the purpose of the audit but,
if an error was detected that might involve a potential
danger to the patient, the caregivers were immediately
informed. During this first 12-month period, the 23 re-
sources and procedures were audited, so RSAs were
only performed on the medication pumps when the
card was randomly selected. When that occurred, all
the pumps currently in use in all the neonates in the
NICU were audited. In the case of the infusion pumps,
the audited variables were: line type (central/peripheral),
pressure alarm programmed (yes/no), appropriate pres-
sure alarm (yes/no) (it was considered appropriate when
programmed to 30–50 mmHg above the working
pressure), volume to infuse programmed (yes/no), cor-
rect programming for volume to infuse (yes/no), cor-
rect infusion rate (yes/no). In addition, an outcome
variable called appropriate use was defined. In this
variable, the overall outcome was very demanding
since the outcome appropriate use was only assigned
when all the evaluated items were completely correct
for a same device. In the following months all the data
collected from the infusion pump audits were analysed
and strategies to improve the way the pumps and their
safety systems are used were planned. Firstly, these
strategies consisted of updating the drug library and
changing the software of all the unit’s pumps for
others with better safety filters (Guardrails CQI Event
Reporter®, CareFusion). This program allows predeter-
mined relative and absolute drug infusion rate limits
to be set. If the relative limits (both upper and lower)
are breached, an alarm sounds, but the infusion is
allowed to continue by confirming the program. If the
absolute limit (only the upper limit) is breached, the
alarm requires the infusion to be cancelled or the
pump to be reprogrammed correctly. In addition, it is
possible to collect prospective data automatically and
to analyse data on intravenous drug infusion program-
ming, which enabled us to analyse the intravenous
medication programming data for 2014. In our unit
these pumps are used for volume bolus infusions and
platelet transfusions as well as for administering intra-
venous medication. Similarly, a low-pressure alarm
was pre-established by default (60 mmHg), which the
nurse could change as appropriate.
At the same time, theoretical training sessions and
practical workshops on using the syringe pumps were
given to all doctors and nurses in the Unit. Furthermore,
a detailed written protocol was prepared on program-
ming and using these pumps, accessible to all Unit
personnel.
After these interventions, audits were performed again,
evaluating only the infusion pumps over a 3-month
period (1 November 2014 to 31 January 2015), to verify
the efficacy of the strategy. Two days a week, selected at
random, in a shift also selected at random, an RSA was
performed on all the medication pumps currently in
use in the NICU. As only the medication pumps were
audited in this second period, a large number of data
were collected, so collection was not continued for a
full year. The degree of agreement between the two
investigators was analysed by simultaneous rounds of
audits.
Other variables
Data was collected about the patient, time, and the
characteristics of the place of admission to the NICU
to assess if they influenced the use of the equipment’s
safety mechanisms: birth weight, gestational age, sex,
working day or weekend/holiday, morning or after-
noon shift, NICU occupancy at the time of audit, and
location of the patient within the unit. It was not
necessary to request informed consent for the pa-
tients, since the use of infusion pumps on hospita-
lised patients is normal practice and the study did
not involve any changes to the therapeutic treatment,
the study object was the infusion devices and the in-
formation related to the patients was confidential
(through a study code).
Ethical issues
This study involved quality strategies for improving pa-
tient safety and thus did not require institutional Review
Board approval. The objetive of the study is a service
audit and no formal review is required by the Ethics
Committee under current Spanish law. The study con-
sent was obtained from the Head Doctor and the Head
Nurses of the Unit.
Analysis plan
Continuous variables are presented as mean ± SD and
categorical variables as absolute and relative frequencies.
The reproducibility of the observations made by the two
study investigators was estimated with the kappa coeffi-
cient. The statistical significance of the comparison of
proportions was determined using chi-squared or
Fisher’s exact test from contingency tables. Comparisons
of the distributions of ordinal and continuous measure-
ments were made using the Wilcoxon–Mann–Whitney
test or Student t-test, as appropriate. Logistic regression
analysis was used to estimate the strength of correlation
between appropriate use and several covariates such as
gestational age, birth weight, sex, location in the NICU,
working days and weekends/holidays, shift, month and
occupancy. Results are presented as odds ratios and
95 % confidence intervals (CI).
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Results
Random safety audits
During the first study period 10 rounds of audits were
performed, which collected a total of 52 infusion pump
measurements of a total of 32 patients. During the sec-
ond study period 25 rounds of audits were performed
that collected a total of 160 measurements (83 patients).
The kappa coefficient of inter-observer agreement be-
tween the two investigators performing the audits was
0.93.
The results for the assessed variables are shown in
Table 1. The frequency of appropriate pump use was
73.13 % (117/160) in the second period compared to 0 %
(0/52) in the first period (p < 0.0001). During the first
study period, the patient characteristics, time, and loca-
tion in the unit did not influence the appropriate use of
the infusion pumps (see Table 2). It was not possible
to compare working days with weekends/holidays in
the first period because by chance all the days on
which the pumps were assessed were working days
(during the first period, audits were carried out on 29
non-working days but, as 23 technological resources/
procedures were audited at random, the audit card
for the infusion pumps was not drawn on any of
these non-working days).
During the second study period, the frequency of ap-
propriate use of infusion pumps was significantly higher
in the small area 82.28 % (65/79) versus 64.20 % (52/81)
in the large area (p < 0.01) (Table 3). Patient charac-
teristics, time, and unit occupancy did not influence
the appropriate use of the infusion pumps.
Programming intravenous medication
Data was collected on the programming of 44,924 infu-
sions of intravenous medication in 2014. In 46.03 %
(20,680/44,924) of cases the name of the drug adminis-
tered was recorded in the safety program. The drugs
most commonly administered by intravenous infusion
during the year are shown in Fig. 1. In 2.5 % (532/
20,680) of the cases, there was an attempt to exceed the
absolute limit when programming the infusion. This
occurred in 4.46 % (323/7,246) of the programmed fen-
tanyl infusions and in 11.21 % (204/1,819) of the pro-
grammed midazolam infusions. Together fentanyl and
midazolam account for 99.05 % of the cases in which
there was an attempt to exceed the absolute limit.
Figure 2 shows the monthly distribution of safety
alarms in the medication programming, detected by the
new software, and Fig. 3 shows the hourly distribution.
Discussion
This study shows how the use of the infusion pumps be-
fore the intervention was not appropriate, especially in
relation to the maximum infusion pressure limit. Chan-
ging the Alaris CC pump program to the Guardrails
CQI Event Reporter® system and implementing the
training sessions resulted in a very significant improve-
ment in the appropriate use of the pumps and also pre-
vented overdose errors. The best use of the pumps was
essentially due to programming appropriately the max-
imum infusion pressure alarm, but other parameters
were also significantly improved such as programming
correctly the volume to infuse during a specific period of
time, which has clinical relevance as an added safety
measure. It is estimated that 30–60 % of administration
errors for intravenous medication are related to using in-
fusion pumps [5]. Despite the crucial role that the
pumps have in administering medication in the neonatal
population, the authors have not identified any previous
study in which Random Safety Audits have been per-
formed in a NICU to assess these aspects or which have
assessed the usefulness of infusion pump safety systems
in neonatology.
The RSA enabled detection of a generalised incorrect
use of the pumps in the first study period. In most cases,
this was due to the pressure limit being too high
(120 mmHg) and not correctly adjusted by the
personnel. The pressure will depend on different factors
such as line type (central or peripheral), catheter type, or
infusion rate. It seems that extravasation can occur dur-
ing gravity infusions with pressure of around 70 mmHg.
As such, the infusion pump manufacturers recommend
Table 1 Frequency of assessed variables during the rounds of syringe infusion pump audits
Alaris® CC Syringe Pumps (N measurements) N Appropriate Use % (Confidence Interval)
Period 1 (N 52) Period 2 (N 160) Period 1 Period 2 P value
Line Type Central 35 117 67.31 (54.56–80.05) 73.13 (66.26–79.99) 0.5275
Pressure alarm Programmed Yes 48 160 92.31 (85.07–99.55) 100 (97.72–100) 0.0031
Programmed Good 1 132 1.92 (1.81–5.65) 82.50 (76.61–88.39) 0.0001
VTI Programmed Yes 37 134 71.15 (58.84–83.46) 83.75 (78.03–89.47) 0.0725
Programmed Good 26 134 50 (36.41–63.59) 83.75 (78.03–89.47) 0.0001
Infusion rate Good 51 160 98.08 (94.34–100) 100 (97.72–100) 0.5529
Appropriate use Yes 0 117 0 (0–6.85) 73.13 (66.26–79.99) <0.0001
VTI: volume to infuse in a certain time
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Table 2 First study period: analysis of factors that could influence the studied infusion pump variables
Period 1
(N measurements)
Birth weight (g) Gestational age (w) Sex Shift Location
(N 51)* (N 52) (N 52) (N 52) (N 52)









Type of line = central %
(N 35)
46.67 (7/15)* 75 (27/36)* 0.01 47.37 (9/19) 78.79 (26/33) 0.03 66.67 (18/27) 68 (17/25) 1 76.47 (13/17) 62.86 (22/35) 0.36 78.95 (30/38) 35.71 (5/14) 0.06
% Pressure alarm
programmed (N 48)
93.33 (14/15)* 91.67 (33/36)* 1 94.74 (18/19) 90.91 (30/33) 1 96.30 (26/27) 88 (22/25) 0.34 100 (17/17) 88.57 (31/35) 0.29 92.11 (35/38) 92.86 (13/14) 1
% Pressure alarm
appropriate (N 1)
0 (0/15)* 1.96 (1/36)* 1 0 (0/19) 3.03 (1/33) 1 3.70 (1/27) 0 (0/25) 1 0 (0/17) 2.86 (1/35) 1 2.63 (1/38) 0 (0/14) 1
% VTI programmed
(N 37)
80 (12/15)* 66.67 (24/36)* 0.5 78.95 (15/19) 66.67 (22/33) 0.52 74.07 (20/27) 68 (17/25) 0.76 64.71 (11/17) 74.29 (26/35) 0.52 65.79 (25/38) 85.71 (12/14) 0.3
% VTI appropriate
(N 26)
66.67 (10/15)* 44.44 (16/36)* 0.22 57.89 (11/19) 45.45 (15/33) 0.56 51.85 (14/27) 48 (12/25) 1 35.29 (6/17) 57.14 (20/35) 0.23 44.74 (17/38) 64.29 (9/14) 0.34
% Infusion rate
appropriate (N 51)
100 (15/15)* 97.22 (35/36)* 1 100 (19/19) 96.97 (32/33) 1 96.30 (26/27) 100 (25/25) 1 100 (17/17) 97.14 (34/35) 1 97.37 (37/38) 100 (14/14) 1
% Appropriate use
(N 52)
0 (0/15)* 0 (0/36)* - 0 (0/19) 0 (0/33) - 0 (0/27) 0 (0/25) - 0 (0/17) 0 (0/35) - 0 (0/38) 0 (0/14) -











Table 3 Second study period: analysis of factors that could influence the studied infusion pump variables
Period 2 (N measurements) Birth weight (g) Gestational age (w) Sex
(N 160) (N 160) (N 160)
<1500 (114/160) ≥1500 (46/160) p <32 (116/160) ≥32 (44/160) p Male (91/160) Female (69/160) p
Type of line = central % (N 117) 72.81 (83/114) 73.91 (34/46) 1 73.28 (85/116) 72.73 (32/44) 1 63.74 (58/91) 85.51 (59/69) 0.002
% Pressure alarm programmed (N 160) 100 (114/114) 100 (46/46) - 100 (116/116) 100 (44/44) - 100 (91/91) 100 (69/69) -
% Pressure alarm appropriate (N 132) 82.46 (94/114) 82.61 (38/46) 1 81.90 (95/116) 84.09 (37/44) 0.81 86.81 (79/91) 76.81 (53/69) 0.14
% VTI programmed (N 134) 85.09 (97/114) 80.43 (37/46) 0.48 84.48 (98/116) 81.82 (36/44) 0.81 91.21 (83/91) 73.91 (51/69) 0.004
% VTI appropriate (N 134) 85.09 (97/114) 80.43 (37/46) 0.48 84.48 (98/116) 81.82 (36/44) 0.81 91.21 (83/91) 73.91 (51/69) 0.004
% Infusion rate appropriate (N 160) 100 (114/114) 100 (46/46) - 100 (116/116) 100 (44/44) - 100 (91/91) 100 (69/69) -
% Appropriate use (N 117) 75.44 (86/114) 67.39 (31/46) 0.32 75 (87/116) 68.18 (30/44) 0.42 81.32 (74/91) 62.32 (43/69) 0.01
Period 2 (N measurements) Day Shift Placement
(N 160) (N 160) (N 160)
Work day (105/160) Holiday (55/160) p Morning (67/160) Afternoon (93/160) p Large box (81/160) Small box (79/160) p
Type of line = central % (N 117) 74.29 (78/105) 70.91 (39/55) 0.7 68.66 (46/67) 76.43 (71/93) 0.28 62.96 (51/81) 83.54 (66/79) 0.004
% Pressure alarm programmed (N 160) 100 (105/105) 100 (55/55) - 100 (67/67) 100 (93/93) - 100 (81/81) 100 (79/79) -
% Pressure alarm appropriate (N 132) 83.81 (88/105) 80 (44/55) 0.66 80.60 (54/67) 83.87 (78/93) 0.67 72.84 (59/81) 92.41 (73/79) 0.001
% VTI programmed (N 134) 80 (84/105) 90.91 (50/55) 0.11 83.58 (56/67) 83.87 (78/93) 1 85.19 (69/81) 82.28 (65/79) 0.67
% VTI appropriate (N 134) 80 (84/105) 90.91 (50/55) 0.11 83.58 (56/67) 83.87 (78/93) 1 85.19 (69/81) 82.28 (65/79) 0.67
% Infusion rate appropriate (N 160) 100 (105/105) 100 (55/55) - 100 (67/67) 100 (93/93) - 100 (81/81) 100 (79/79) -
% Appropriate use (N 117) 71.43 (75/105) 76.36 (42/55) 0.57 71.64 (48/67) 74.19 (69/93) 0.72 64.20 (52/81) 82.28 (65/79) 0.01











individual setting of the pressure limit and programming
it to 20–50 mmHg above the baseline pressure [11, 12].
After analysing all the data collected during the first
period, and alarmed by the inappropriate use of the
pumps, we designed different strategies to urgently
improve this aspect of patient safety. A lower default
pressure limit alarm was preset (60 mmHg), which could
be modified by the nurse as appropriate.
The new Guardrails CQI Event Reporter® software,
CareFusion, was installed on the pumps. It is a medica-
tion safety and quality auditing system specifically de-
signed for infusions that presents a series of advantages.
Firstly, the built-in drug library has more intuitive and
simple programming. The doses, concentrations, and
specific dose limits for the neonatal population were also
updated in the drug library. Secondly, the new software
allowed data on administration of medication and pump
usage to be stored: the data recorded on the infusion
devices is very useful to monitor compliance with the
unit’s recommendations and protocols [5]. Infusion
pumps with these built-in safety systems are known as
smart infusion pumps [13, 14].
The data recorded during the year after introducing
the new software showed the extremely large number of
programmed infusions and, thus, the importance any
measure that increases their safety can have. In one year,
the installed safety program detected more than 500 at-
tempts to program infusions with a dose above the
present absolute safety limits. This means that the pump
Fig. 1 The most commonly used drugs in our unit in 2014. Fentanyl
35.04 % (7,246/20,680), Gentamicin 12.58 % (2,601/20,680), Dopamine
10.73 % (2,218/20,680), Vancomycin 9.49 % (1,962/20,680), and
Midazolam 8.80 % (1,819/20,680)
Fig. 2 Distribution by month of alarms detected in medication programming in 2014
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safety program was effective in preventing drug over-
doses and their potential adverse effects in patients in a
large number of cases, results which are similar to those
of other studies [13–18]. Most attempts to exceed the
absolute limits occurred with two drugs: fentanyl and
midazolam; consequently, their protocols will have to be
reviewed in order to identify why there is a tendency to
program an excessive dose.
In our NICU, most alarms occurred around 10:00–
11:00 a.m. and around 4:00–5:00 p.m., which coincide
respectively with the time when the neonatologists
change the treatment prescriptions and the period after
the change in nursing shift, when the nurses start
administering the medication. This differs from other
studies, in which the time of greatest error coincides
with the change in nursing shift or with other medica-
tion administration times [17, 19]. The months in which
most alarms were detected due to attempts to exceed
the relative and absolute limits in the programming of
intravenous medication were January and February 2014,
twice as many as in the other months of the year. We
cannot explain this result since the NICU occupancy
was practically the same throughout the year (96 %) and
the introduction of the safety program and the personnel
training had ended approximately 6 months earlier.
No relation between appropriate use of the pumps and
patient characteristics has been found. However, the
RSA performed during the second study period showed
that pump use was better in the NICU small boxes. This
is probably explained by the fact that perhaps there are
fewer interruptions in the smaller areas, with fewer pa-
tients and less personnel, and this probably contributes
to a higher concentration of staff when the pump safety
systems are programmed.
Fig. 3 Distribution by time of day of alarms detected in medication programming in 2014
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Although the smart infusion pumps have the potential
to reduce errors [20], their efficacy is often compromised
in daily clinical practice by a lack of compliance with the
recommendations/protocols for use, overlooking their
safety alarm systems or ignoring alarms. Several studies
show that one of the possible causes is nurses’ lack of
experience, in particular those with less than 6 years’
experience [21]. They also show how nurse training ef-
fectively contributes to decreasing the frequency and
severity of errors related to intravenous medication
[21–23]. For this reason, theoretical sessions and prac-
tical workshops were given to doctors and nurses in
our unit to improve the training in the use of these
devices, thereby increasing awareness of the import-
ance of complying with the protocols.
Our results show that the name of the drug adminis-
tered was recorded in the safety program in 46.03 % of
cases. However, we cannot interpret this result as adher-
ence to the use of the program since in our unit the syr-
inge pumps are also used for other infusions (saline
solution or platelet transfusions) that are not included in
the program’s drug library. As such, in the 54 % of cases
in which a drug name was not recorded we cannot know
in which cases it was due to an incorrect use of the
safety program because the drug was in the library or in
which cases the infusion was a saline bolus or other
medication that is not in the library and so no name
could be recorded.
During the second study period, audits were per-
formed for only three months as, out of the 23 techno-
logical equipment/procedures included in the initial
study, only the infusion pumps were being audited and
because the results obtained showed a large improve-
ment compared to the first period.
Although this use of RSAs may be surprising, as they
have traditionally been used for monitoring, as men-
tioned in the introduction, they can also be used to
consistently detect unknown weakness which, once iden-
tified, could lead to interventions. These procedures can
continue to be monitored after the intervention. Error
identification by audits maintained over time can iden-
tify repeated weaknesses in the system that do not de-
pend on either the professionals working at any given
time or on the circumstances.
One of the limitations of this study is that the extrava-
sations of the lines that occurred during the study pe-
riods were not recorded; this would have enabled the
clinical impact of better programming of the pump infu-
sion pressure limit to be known. Also audits were not
performed during the night shift. In the first period, as
previously noted, all the days when the pumps were
audited were (by chance) working days. In the second
period, working days and weekends/holidays were stud-
ied, and no differences in use were identified.
Conclusion
The Random Safety Audits were a very useful tool for
detecting inappropriate use of the pumps in a Neonatal
Intensive Care Unit. Introducing safety software on the
infusion pumps, preparing a written protocol for use,
and training sessions were effective strategies for im-
proving appropriate use of the infusion pumps for intra-
venous medication in our NICU.
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